(AOF) – Adocia
Adocia announces that its annual general meeting (AGM) will be held on June 28 at 10 a.m., at the Hôtel de Talleyrand, in the offices of the firm Jones Day, 2 rue Saint Florentin, in Paris. “Only shareholders who have registered their shares no later than the second business day preceding the date set for the AGM, at midnight, Paris time, will be able to physically participate in the AGM”, specifies the biotechnology company.
Elis’ combined general meeting of shareholders, held on May 19, 2022, approved the payment of a dividend of €0.37 per share for the 2021 financial year and decided to offer each shareholder an option for the payment of this dividend in cash or in new shares. The option for payment of this dividend in new shares may only relate to the entire dividend relating to the shares owned by said shareholder.
Gaussin has signed an exclusive 20-year agreement with Charbone Hydrogen for the local assembly and marketing of zero-emission APM and ATM vehicles in Canada. The contract includes an initial entry fee of 10 million euros including all costs, including development costs already accounted for the development of Gaussin products, royalties of 5% for future developments and exclusivity covering Canada .
Getlink is modernizing its fleet of Euro4000 locomotives by investing in ETCS (European Train Control System) technology. Europorte is the first French rail freight company to equip 10 Euro4000 locomotives with this innovative rail signaling technology which will promote the growth of its international business. To carry out this project, Europorte and Beacon commissioned the Belgian company Transurb, which specializes in the integration of railway signaling technologies.
Last Friday evening, Lhyfe announced the success of its IPO. The share price of the producer and supplier of green hydrogen was set at 8.45 euros, ie at the bottom of the range of 8.75 to 11.75 euros. This price implies a market capitalization of approximately 411 million euros. Trading in the shares (in the form of pledges) begins this morning. Settlement takes place tomorrow. The group carried out a capital increase of 110 million which could be increased to 124 million in the event of full exercise of the over-allotment option.
The United States Food and Drug Administration (FDA) has approved Dupixent (dupilumab) 300 mg once weekly for the treatment of eosinophilic esophagitis in patients 12 years of age and over weighing at least 40 kg . “With this approval, Dupixent becomes the first and only drug specifically indicated for the treatment of eosinophilic esophagitis in the United States,” said Sanofi.
Wavestone confirms that it meets all the PEA-PME eligibility criteria specified in article L.221 32-2 of the Monetary and Financial Code. As a result, Wavestone shares can continue to be integrated into PEA-PME accounts, which, as a reminder, benefit from the same tax advantages as the traditional equity savings plan (PEA). The group will publish its annual results on May 31, 2022.